DE2141289A1 - Spray-Vakzinen - Google Patents

Spray-Vakzinen

Info

Publication number
DE2141289A1
DE2141289A1 DE19712141289 DE2141289A DE2141289A1 DE 2141289 A1 DE2141289 A1 DE 2141289A1 DE 19712141289 DE19712141289 DE 19712141289 DE 2141289 A DE2141289 A DE 2141289A DE 2141289 A1 DE2141289 A1 DE 2141289A1
Authority
DE
Germany
Prior art keywords
lecithin
vaccines
virus
antigens
dispersed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19712141289
Other languages
German (de)
English (en)
Inventor
Jan Weesp Jacobs (Niederlande)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of DE2141289A1 publication Critical patent/DE2141289A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE19712141289 1970-08-29 1971-08-18 Spray-Vakzinen Withdrawn DE2141289A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7012832A NL7012832A (es) 1970-08-29 1970-08-29

Publications (1)

Publication Number Publication Date
DE2141289A1 true DE2141289A1 (de) 1972-03-09

Family

ID=19810895

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712141289 Withdrawn DE2141289A1 (de) 1970-08-29 1971-08-18 Spray-Vakzinen

Country Status (7)

Country Link
US (1) US3755557A (es)
BE (1) BE771918A (es)
CA (1) CA971480A (es)
DE (1) DE2141289A1 (es)
FR (1) FR2103608B1 (es)
GB (1) GB1302671A (es)
NL (1) NL7012832A (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
FR2423217A2 (fr) * 1978-03-10 1979-11-16 Anvar Procede de vaccination contre la myxomatose
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
EP0009277B1 (en) * 1978-09-14 1984-04-18 Gist-Brocades N.V. Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
NL7812359A (nl) * 1978-12-20 1980-06-24 Gist Brocades Nv Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
NL8102786A (nl) * 1981-06-10 1983-01-03 Duphar Int Res Werkwijze voor het immuniseren van varkens tegen de ziekte van aujeszky.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
WO1986006959A1 (en) * 1985-05-22 1986-12-04 Liposome Technology, Inc. Liposome inhalation method and system
CA2097830C (en) * 1990-12-04 2000-02-01 Stephen G. Newman Spray-dried antigenic products and method of preparation
ATE386506T1 (de) * 1995-10-17 2008-03-15 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
WO1999040906A2 (en) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
ID29270A (id) 1998-11-20 2001-08-16 Rtp Pharma Inc Partikel-partikel mikro yang distabilkan oleh fosfolipid yang dapat menyebar
EP1214059B1 (en) * 1999-09-21 2005-05-25 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
CA2407027C (en) 2000-04-20 2011-02-15 Rtp Pharma Inc. Improved water-insoluble drug particle process
CA2420597C (en) 2000-08-31 2011-05-17 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
ATE357216T1 (de) * 2001-02-22 2007-04-15 Jagotec Ag Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
MXPA04004726A (es) * 2001-11-19 2004-07-30 Becton Dickinson Co Composiciones farmaceuticas en forma particulada.
JP2006517913A (ja) * 2003-02-13 2006-08-03 ベクトン・ディキンソン・アンド・カンパニー 改良型炭疽ワクチンおよび送達方法
CN102648003B (zh) * 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
CN103386125A (zh) * 2012-05-08 2013-11-13 刘江秋 肾综合征出血热鼻黏膜免疫气溶胶疫苗的研制
CN107475204A (zh) * 2017-08-03 2017-12-15 中国人民解放军军事医学科学院军事兽医研究所 一种囊膜病毒保护剂及其制备方法

Also Published As

Publication number Publication date
FR2103608A1 (es) 1972-04-14
US3755557A (en) 1973-08-28
NL7012832A (es) 1972-03-02
CA971480A (en) 1975-07-22
BE771918A (fr) 1972-02-28
FR2103608B1 (es) 1975-02-07
GB1302671A (es) 1973-01-10

Similar Documents

Publication Publication Date Title
DE2141289A1 (de) Spray-Vakzinen
DE69529224T2 (de) IMPFSTOFF-ZUSAMMENSETZUNGEN enthaltend teil-deacetyliertes Chitin
DE3911442A1 (de) Impfstoff-praeparation
WO1989007946A1 (en) Virally modified tumour vaccines for immunotherapy of tumour metastases
CH637422A5 (de) Verfahren zur attenuierung oder inaktivierung von pathogenen mikroorganismen.
DE69923470T2 (de) Kombinationsimpfstoff gegen hav und masernvirus und verfahren zu seiner produktion
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2643641A1 (de) Antigene praeparate und verfahren zu ihrer herstellung
DE2323847C3 (de) Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
DE69333730T2 (de) Impfstoff, der acemannan als adjuvans enthält
DE2405675A1 (de) Verfahren zur inaktivierung von viren und die herstellung von vakzinen
CH423095A (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
DE2425997A1 (de) Verfahren zur herstellung von abgeschwaechtem katzenfiebervakzin
DE1617545C2 (de) Verwendung von informatorischer Ribonucleinsäure als Vaccine
DE2632255A1 (de) Neues rabiesvirusvakzin und verfahren zu dessen herstellung
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
DE1492243C3 (de) Injizierbare Impfstoffe
DE2528584A1 (de) Verfahren zur inaktivierung der virusinfektiositaet unter gleichzeitiger stabilisierung von virusantigenen
DE1246167B (de) Verfahren zur Herstellung von Influenza-Vaccinen
DD298884A5 (de) Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
GB806949A (en) Production of pharmaceutical preparations
AT234902B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
DE1021128B (de) Verfahren zur Herstellung eines Impfstoffes gegen die Rhinotracheitis der Rinder

Legal Events

Date Code Title Description
OD Request for examination
8139 Disposal/non-payment of the annual fee